Francois Carbonnel - Amgen Insider

Amgen Inc -- USA Stock  

USD 186.11  0.18  0.10%

Independent Director

Mr. Francois de Carbonnel is an Independent Director of Amgen Inc. Franois de Carbonnel is a director of corporations and corporate advisor. Mr. de Carbonnel was a member of the group governance council of Mazars Group, a privatelyheld international organization specializing in audit, accountancy, tax, legal and advisory services, from December 2011 to January 2016. From 2004 to May 2015, Mr. de Carbonnel was a director of Solocal Group, a French company which offers online content, advertising solutions and transactional services, and served as Chairman of the Remuneration and Appointments Committee. From 2004 until October 2013, Mr. de Carbonnel was a director of a number of funds managed by Ecofin, a privatelyheld investment management firm. Mr. de Carbonnel was a director of Thomson S.A., a French multimedia corporation, from 2007 to January 2010, serving as Chairman of the Audit Committee throughout his tenure, and as nonexecutive Chairman of the Board from April 2008 to April 2009. Mr. de Carbonnel was a director of Quilvest S.A., a Luxembourg company which provides wealth management and private equity services, from 2006 to 2013.
Age: 69  Director Since 2008      
805 447-1010  www.amgen.com

Management Efficiency

The company has return on total asset (ROA) of 8.27 % which means that it generated profit of $8.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 26.43 % meaning that it created $26.43 on every $100 dollars invested by stockholders.
The company currently holds 35.06 B in liabilities with Debt to Equity (D/E) ratio of 110.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 6.08 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

James FarrellAbbott Laboratories
2006
William YoungVertex Pharmaceuticals Incorpor
2014
David GreenwayVertex Pharmaceuticals Incorpor
2017
Haiyuan LoQuintiles IMS Holdings Inc
2015
James BloemAllergan plc
2013
Douglas IngramEndo International plc
2016
Christopher GordonQuintiles IMS Holdings Inc
2009
Peter McDonnellAllergan plc
2015
Nesli BasgozAllergan plc
2014
Nancy McKinstryAbbott Laboratories
2011
W FarrellAbbott Laboratories
2006
Sally BlountAbbott Laboratories
2011
Todd SisitskyQuintiles IMS Holdings Inc
2016
Nancy HutsonEndo International plc
2009
Ari BousbibQuintiles IMS Holdings Inc
2016
Leonard SchaefferQuintiles IMS Holdings Inc
2008
Terrence KearneyVertex Pharmaceuticals Incorpor
2011
Ron TaylorAllergan plc
2013
Jack GreenbergQuintiles IMS Holdings Inc
2016
James FasanoQuintiles IMS Holdings Inc
2016
Michael HyattEndo International plc
N/A

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 17,900 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run ETF Directory Now
   

ETF Directory

Find actively-traded Exchange Traded Funds (ETF) from around the world
Hide  View All  Next  Launch ETF Directory
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amgen Inc to your portfolio

Top Management

Amgen Inc Leadership Team
Frank Herringer, Director
R Williams, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance

Amgen Performance Indicators